Abstract
BackgroundFunctional autoantibodies against the angiotensin II receptor type 1 (AT1R) and the endothelin receptor type A (ETAR) have been identified in patients suffering from systemic sclerosis (SSc) [1].ObjectivesAim of the...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have